Author

Javier Jose Mallada

Observed names: J J Mallada, J Mallada, Javier Mallada

Observed institution: Hospital General de Elda

OpenAlex ID: A5015068980

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

2017 · Bonaventura Casanova, Isidro Jarque, et al. · Neurological Sciences · 61

PDF

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required

2009 · Ana M Pascual, Neus Téllez, et al. · Multiple Sclerosis Journal · 57

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

2022 · Carmen Alcalá, Carlos Quintanilla-Bordás, et al. · Journal of Neurology · 25

Primary Cough Headache Responsive to Topiramate

2005 · V Medrano, J Mallada, et al. · Cephalalgia · 21

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series

2022 · Carlos Quintanilla-Bordás, Francisco Gascón-Gimenez, et al. · Frontiers in Neurology · 16

PDF

Diagnosis by axilla skin biopsy in an early case of Lafora's disease.

1992 · G Rubio, C Garcia Guijo, et al. · Journal of Neurology Neurosurgery & Psychiatry · 12

PDF

Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia

2019 · Sergi Borrego‐Écija, Anna Antonell, et al. · Annals of Clinical and Translational Neurology · 9

PDF

Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients

2018 · Bonaventura Casanova, Laura Lacruz, et al. · Neurological Sciences · 8

MR and CT diagnosis of intracranial lipoma.

1991 · G Rubio, C Garcia Guijo, et al. · American Journal of Roentgenology · 8

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis

2022 · Carmen Alcalá Vicente, Laura Lacruz, et al. · Frontiers in Neurology · 6

PDF

Effectiveness and safety of fingolimod in Spanish Relapsing-Remitting Multiple Sclerosis patients in clinical practice (Fingoview study): Subanalysis of patients previously treated with first line injectable disease-modifying treatment

2017 · Javier Mallada

Tolerability and safety of Fingolimod in Spanish Clinical practice. Pooled Analysis data: Study Fingoview (P5.396)

2017 · Guillermo Izquierdo, Jose Meca-Lallana, et al. · Neurology

[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in the province of Alicante].

2016 · J Mallada, N Perez-Carmona, et al. · PubMed

Interim Analysis Results of an Observational, Retrospective, Multicenter Study to Assess the Effectiveness of Fingolimod Treatment in Clinical Practice in Patients with Relapsing-Remitting Multiple Sclerosis in Spain: The NEXT Study (P3.096)

2016 · Javier Jose Mallada, Francisco Barrero, et al. · Neurology

Interim Analysis of the Effectiveness of Second-Line Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients Treated with Prior First-Line Treatment, Other Than Natalizumab, in Spain: The Observational, Retrospective NEXT Study (P3.106)

2016 · Virginia Meca, Marisa Martínez, et al. · Neurology

Stress burden and satisfaction with treatment in caregivers and patients with Multiple Sclerosis. MS-Feeling Study (P5.208)

2015 · Meca-Lallana Jose, Maria Del Mar Mendibe Bilbao, et al. · Neurology

Positron emission tomography: a false negative result in cystic encephalic mestastases from a small cell bronchial carcinoma

2006 · David Orts Giménez, Rosa Jiménez Yáñez, et al. · Clinical & Translational Oncology

[Familial periodic ataxia with myokymia sensitive to acetazolamide: a family case].

1997 · F Gómez-Gosálvez, P Smeyers, et al. · PubMed

Works count: 18

Citation count: 223

H-index: 8

I10-index: 6